Stem Cells · 2023 · 23 citations · 24 references
Life SciencesCell BiologyNeuroscienceDevelopmental NeuroscienceStem Cell BiologyTissue EngineeringNervous TissueNeural Stem CellsNeural Tissue EngineeringOrganoid EngineeringTissue ArchitectureTissue Engineering With Stem CellsInduced Pluripotent Stem CellsNeuroepithelial Cell ProliferationOrganoid-based Neural ModelsOrganoidsTissue-engineered ConstructsVascularizationVascularized Tissue ConstructsVascularized Tissue Models
Advanced technologies have enabled the engineering of self-organized 3-dimensional (3D) cellular structures from human induced pluripotent stem cells (hiPSCs), namely organoids, which recapitulate some key features of tissue development and functions of the human central nervous system (CNS). While hiPSC-derived 3D CNS organoids hold promise in providing a human-specific platform for studying CNS development and diseases, most of them do not incorporate the full range of implicated cell types, including vascular cell components and microglia, limiting their ability to accurately recreate the CNS environment and their utility in the study of certain aspects of the disease. Here we have developed a novel approach, called vascularized brain assembloids, for constructing hiPSC-derived 3D CNS structures with a higher level of cellular complexity. This is achieved by integrating forebrain organoids with common myeloid progenitors and phenotypically stabilized human umbilical vein endothelial cells (VeraVecs), which can be cultured and expanded in serum-free conditions. Compared with organoids, these assembloids exhibited enhanced neuroepithelial proliferation, advanced astrocytic maturation, and increased synapse numbers. Strikingly, the assembloids derived from hiPSCs harboring the tauP301S mutation exhibited increased levels of total tau and phosphorylated tau, along with a higher proportion of rod-like microglia-like cells and enhanced astrocytic activation, when compared to the assembloids derived from isogenic hiPSCs. Additionally, the tauP301S assembloids showed an altered profile of neuroinflammatory cytokines. This innovative assembloid technology serves as a compelling proof-of-concept model, opening new avenues for unraveling the intricate complexities of the human brain and accelerating progress in the development of effective treatments for neurological disorders.
24
iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases
Edsel M. Abud, Ricardo N. Ramírez, Eric S. Martinez et al. · Neuron · 2017 · 1.2K citations · Full text
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Kiran Bhaskar, Megan E. Konerth, Olga N. Kokiko‐Cochran et al. · Neuron · 2010 · 653 citations · Full text
Medicine, Neurobiology, Neuroscience +14
Generation of vascularized brain organoids to study neurovascular interactions
Xin-Yao Sun, Xiang-Chun Ju, Yang Li et al. · eLife · 2022 · 364 citations · Full text
Medicine, Neurobiology, Neuroscience +17
Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy
Chao Wang, Li Fan, Rabia R. Khawaja et al. · Nature Communications · 2022 · 317 citations · Full text